Pfizer (PFE) and Bristol-Meyers (BMY) win FDA approval for Eliquis
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Join SI Premium – FREE
Pfizer, Inc. (NYSE: PFE) and Bristol-Meyers (NYSE: BMY) win FDA approval for Eliquis, according to Bloomberg headlines.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA maintains underperform ratings on six BDC stocks
- Is the global equity rally broadening? UBS weighs in
- Gossamer Bio raises up to $250M in private placement for PAH drug
Create E-mail Alert Related Categories
FDA, General NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
